A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer Journal Article
| Authors: | Harding, J. J.; Fan, J.; Oh, D. Y.; Choi, H. J.; Kim, J. W.; Chang, H. M.; Bao, L.; Sun, H. C.; Macarulla, T.; Xie, F.; Metges, J. P.; Ying, J.; Bridgewater, J.; Lee, M. A.; Tejani, M. A.; Chen, E. Y.; Kim, D. U.; Wasan, H.; Ducreux, M.; Bao, Y.; Lindsey, S.; Bachini, M.; Morement, H.; Boyken, L.; Ma, J.; Garfin, P.; Pant, S.; on behalf of the HERIZON-BTC-01 study group |
| Article Title: | A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer |
| Journal Title: | Future Oncology |
| Volume: | 20 |
| Issue: | 31 |
| ISSN: | 1479-6694 |
| Publisher: | Future Medicine |
| Date Published: | 2024-01-01 |
| Start Page: | 2319 |
| End Page: | 2329 |
| Language: | English |
| DOI: | 10.1080/14796694.2024.2368952 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl plus with full text |
| PMCID: | PMC11524198 |
| PUBMED: | 39114870 |
| DOI/URL: | |
| Notes: | Source: CINAHL Plus with Full Text |
